Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial

E. Guttman-Yassky, L. Bahadori, L. Brooks, K. L. Clark, H. Grindebacke, C. N. Ho, R. Katial, T. H. Pham, C. Walton, C. J. Datto

Research output: Contribution to journalLetterpeer-review

11 Scopus citations
Original languageEnglish
Pages (from-to)e1211-e1214
JournalJournal of the European Academy of Dermatology and Venereology
Volume37
Issue number10
DOIs
StatePublished - Oct 2023

Cite this